Viewing Study NCT01756703


Ignite Creation Date: 2025-12-24 @ 7:40 PM
Ignite Modification Date: 2026-01-08 @ 12:08 AM
Study NCT ID: NCT01756703
Status: COMPLETED
Last Update Posted: 2015-02-09
First Post: 2012-12-20
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With Albuminuria
Sponsor: Tanabe Pharma Corporation
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module